Impact Of Plasma Egfr Mutation Fractions On Response To First Generation Tyrosine-Kinase Inhibitor In Treatment Of Naive Non-Small Cell Lung Cancer PatientsX. Wang,Y. Liu, Z. Meng,Y. Wu,S. Wang, G. Jin,Y. Qin, F. Wang,J. Wang,L. Wang,J. Bai, X. Shi,Z. Wen, X. Jia,X. Fu,X. Wang, Q. Qin, Y. Gao,W. Guo, S. LuANNALS OF ONCOLOGY（2019）引用 0|浏览39暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
